nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PPARG—pancreatic cancer	0.477	1	CbGaD
Pioglitazone—SLCO1B3—Docetaxel—pancreatic cancer	0.0706	0.192	CbGbCtD
Pioglitazone—SLCO1B1—Irinotecan—pancreatic cancer	0.0561	0.153	CbGbCtD
Pioglitazone—CYP2C8—Tamoxifen—pancreatic cancer	0.0309	0.0842	CbGbCtD
Pioglitazone—CYP2C8—Erlotinib—pancreatic cancer	0.0263	0.0716	CbGbCtD
Pioglitazone—CYP2C19—Tamoxifen—pancreatic cancer	0.026	0.0707	CbGbCtD
Pioglitazone—CYP2C8—Fluorouracil—pancreatic cancer	0.0228	0.0621	CbGbCtD
Pioglitazone—CYP2C9—Tamoxifen—pancreatic cancer	0.0216	0.0588	CbGbCtD
Pioglitazone—CYP2D6—Tamoxifen—pancreatic cancer	0.0197	0.0537	CbGbCtD
Pioglitazone—CYP2D6—Erlotinib—pancreatic cancer	0.0168	0.0457	CbGbCtD
Pioglitazone—CYP2C9—Fluorouracil—pancreatic cancer	0.0159	0.0433	CbGbCtD
Pioglitazone—CYP3A4—Tamoxifen—pancreatic cancer	0.0125	0.0342	CbGbCtD
Pioglitazone—CYP3A4—Erlotinib—pancreatic cancer	0.0107	0.0291	CbGbCtD
Pioglitazone—CYP3A4—Irinotecan—pancreatic cancer	0.00964	0.0262	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—pancreatic cancer	0.00828	0.0225	CbGbCtD
Pioglitazone—CYP3A4—Docetaxel—pancreatic cancer	0.00706	0.0192	CbGbCtD
Pioglitazone—CYP3A4—Sunitinib—pancreatic cancer	0.00703	0.0191	CbGbCtD
Pioglitazone—CYP3A4—Doxorubicin—pancreatic cancer	0.00526	0.0143	CbGbCtD
Pioglitazone—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.0032	1	CbGdCrCtD
Pioglitazone—Rosiglitazone—PPARG—pancreatic cancer	0.00224	1	CrCbGaD
Pioglitazone—Malaise—Gemcitabine—pancreatic cancer	0.000215	0.00143	CcSEcCtD
Pioglitazone—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.000215	0.00143	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000214	0.00142	CcSEcCtD
Pioglitazone—Myocardial infarction—Docetaxel—pancreatic cancer	0.000212	0.00141	CcSEcCtD
Pioglitazone—Hypertension—Irinotecan—pancreatic cancer	0.000211	0.00141	CcSEcCtD
Pioglitazone—Hepatic failure—Epirubicin—pancreatic cancer	0.000211	0.0014	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—pancreatic cancer	0.000211	0.0014	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00021	0.00139	CcSEcCtD
Pioglitazone—Fatigue—Sunitinib—pancreatic cancer	0.000209	0.00139	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000209	0.00139	CcSEcCtD
Pioglitazone—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000209	0.00139	CcSEcCtD
Pioglitazone—Discomfort—Irinotecan—pancreatic cancer	0.000206	0.00137	CcSEcCtD
Pioglitazone—Hypertension—Gemcitabine—pancreatic cancer	0.000206	0.00137	CcSEcCtD
Pioglitazone—Asthenia—Tamoxifen—pancreatic cancer	0.000203	0.00135	CcSEcCtD
Pioglitazone—Myalgia—Gemcitabine—pancreatic cancer	0.000203	0.00135	CcSEcCtD
Pioglitazone—Chest pain—Gemcitabine—pancreatic cancer	0.000203	0.00135	CcSEcCtD
Pioglitazone—Arthralgia—Gemcitabine—pancreatic cancer	0.000203	0.00135	CcSEcCtD
Pioglitazone—Increased appetite—Epirubicin—pancreatic cancer	0.000202	0.00134	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000202	0.00134	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000202	0.00134	CcSEcCtD
Pioglitazone—Asthenia—Erlotinib—pancreatic cancer	0.000201	0.00134	CcSEcCtD
Pioglitazone—Discomfort—Gemcitabine—pancreatic cancer	0.000201	0.00133	CcSEcCtD
Pioglitazone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.0002	0.00133	CcSEcCtD
Pioglitazone—Oedema—Irinotecan—pancreatic cancer	0.0002	0.00133	CcSEcCtD
Pioglitazone—Myalgia—Fluorouracil—pancreatic cancer	0.0002	0.00133	CcSEcCtD
Pioglitazone—Chest pain—Fluorouracil—pancreatic cancer	0.0002	0.00133	CcSEcCtD
Pioglitazone—Infection—Irinotecan—pancreatic cancer	0.000199	0.00132	CcSEcCtD
Pioglitazone—Discomfort—Fluorouracil—pancreatic cancer	0.000197	0.00131	CcSEcCtD
Pioglitazone—Nervous system disorder—Irinotecan—pancreatic cancer	0.000196	0.0013	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—pancreatic cancer	0.000195	0.0013	CcSEcCtD
Pioglitazone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000195	0.00129	CcSEcCtD
Pioglitazone—Oedema—Gemcitabine—pancreatic cancer	0.000195	0.00129	CcSEcCtD
Pioglitazone—Hepatitis—Docetaxel—pancreatic cancer	0.000195	0.00129	CcSEcCtD
Pioglitazone—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000194	0.00129	CcSEcCtD
Pioglitazone—Cardiac failure—Epirubicin—pancreatic cancer	0.000194	0.00129	CcSEcCtD
Pioglitazone—Diarrhoea—Tamoxifen—pancreatic cancer	0.000194	0.00129	CcSEcCtD
Pioglitazone—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000194	0.00129	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000194	0.00129	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000194	0.00129	CcSEcCtD
Pioglitazone—Infection—Gemcitabine—pancreatic cancer	0.000193	0.00129	CcSEcCtD
Pioglitazone—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000193	0.00128	CcSEcCtD
Pioglitazone—Pharyngitis—Docetaxel—pancreatic cancer	0.000193	0.00128	CcSEcCtD
Pioglitazone—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000192	0.00128	CcSEcCtD
Pioglitazone—Diarrhoea—Erlotinib—pancreatic cancer	0.000192	0.00128	CcSEcCtD
Pioglitazone—Oedema peripheral—Docetaxel—pancreatic cancer	0.000192	0.00127	CcSEcCtD
Pioglitazone—Oedema—Fluorouracil—pancreatic cancer	0.000191	0.00127	CcSEcCtD
Pioglitazone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000191	0.00127	CcSEcCtD
Pioglitazone—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000191	0.00127	CcSEcCtD
Pioglitazone—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000191	0.00127	CcSEcCtD
Pioglitazone—Urethral disorder—Docetaxel—pancreatic cancer	0.000191	0.00127	CcSEcCtD
Pioglitazone—Infection—Fluorouracil—pancreatic cancer	0.00019	0.00126	CcSEcCtD
Pioglitazone—Pain in extremity—Epirubicin—pancreatic cancer	0.00019	0.00126	CcSEcCtD
Pioglitazone—Skin disorder—Gemcitabine—pancreatic cancer	0.000189	0.00126	CcSEcCtD
Pioglitazone—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000188	0.00125	CcSEcCtD
Pioglitazone—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000188	0.00125	CcSEcCtD
Pioglitazone—Visual impairment—Docetaxel—pancreatic cancer	0.000187	0.00125	CcSEcCtD
Pioglitazone—Dizziness—Tamoxifen—pancreatic cancer	0.000187	0.00125	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—pancreatic cancer	0.000187	0.00124	CcSEcCtD
Pioglitazone—Dizziness—Erlotinib—pancreatic cancer	0.000185	0.00123	CcSEcCtD
Pioglitazone—Eye disorder—Docetaxel—pancreatic cancer	0.000182	0.00121	CcSEcCtD
Pioglitazone—Insomnia—Irinotecan—pancreatic cancer	0.000181	0.0012	CcSEcCtD
Pioglitazone—Cardiac disorder—Docetaxel—pancreatic cancer	0.000181	0.0012	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00018	0.0012	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—pancreatic cancer	0.00018	0.0012	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000179	0.00119	CcSEcCtD
Pioglitazone—Hypersensitivity—Sunitinib—pancreatic cancer	0.000179	0.00119	CcSEcCtD
Pioglitazone—Dyspnoea—Irinotecan—pancreatic cancer	0.000178	0.00118	CcSEcCtD
Pioglitazone—Headache—Tamoxifen—pancreatic cancer	0.000178	0.00118	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000177	0.00118	CcSEcCtD
Pioglitazone—Insomnia—Gemcitabine—pancreatic cancer	0.000176	0.00117	CcSEcCtD
Pioglitazone—Immune system disorder—Docetaxel—pancreatic cancer	0.000176	0.00117	CcSEcCtD
Pioglitazone—Headache—Erlotinib—pancreatic cancer	0.000176	0.00117	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—pancreatic cancer	0.000175	0.00117	CcSEcCtD
Pioglitazone—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000175	0.00117	CcSEcCtD
Pioglitazone—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000175	0.00116	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000174	0.00116	CcSEcCtD
Pioglitazone—Asthenia—Sunitinib—pancreatic cancer	0.000174	0.00116	CcSEcCtD
Pioglitazone—Dyspnoea—Gemcitabine—pancreatic cancer	0.000174	0.00115	CcSEcCtD
Pioglitazone—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000173	0.00115	CcSEcCtD
Pioglitazone—Insomnia—Fluorouracil—pancreatic cancer	0.000173	0.00115	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000173	0.00115	CcSEcCtD
Pioglitazone—Fatigue—Irinotecan—pancreatic cancer	0.000172	0.00115	CcSEcCtD
Pioglitazone—Breast disorder—Epirubicin—pancreatic cancer	0.000171	0.00114	CcSEcCtD
Pioglitazone—Dyspnoea—Fluorouracil—pancreatic cancer	0.000171	0.00113	CcSEcCtD
Pioglitazone—Malnutrition—Docetaxel—pancreatic cancer	0.000169	0.00113	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000168	0.00112	CcSEcCtD
Pioglitazone—Fatigue—Gemcitabine—pancreatic cancer	0.000168	0.00112	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000167	0.00111	CcSEcCtD
Pioglitazone—Diarrhoea—Sunitinib—pancreatic cancer	0.000166	0.0011	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000165	0.0011	CcSEcCtD
Pioglitazone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000165	0.0011	CcSEcCtD
Pioglitazone—Influenza—Epirubicin—pancreatic cancer	0.000164	0.00109	CcSEcCtD
Pioglitazone—Back pain—Docetaxel—pancreatic cancer	0.000164	0.00109	CcSEcCtD
Pioglitazone—Muscle spasms—Docetaxel—pancreatic cancer	0.000163	0.00108	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000162	0.00108	CcSEcCtD
Pioglitazone—Dizziness—Sunitinib—pancreatic cancer	0.00016	0.00107	CcSEcCtD
Pioglitazone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00016	0.00107	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00016	0.00107	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—pancreatic cancer	0.00016	0.00106	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—pancreatic cancer	0.000159	0.00105	CcSEcCtD
Pioglitazone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000158	0.00105	CcSEcCtD
Pioglitazone—Bronchitis—Epirubicin—pancreatic cancer	0.000158	0.00105	CcSEcCtD
Pioglitazone—Anaemia—Docetaxel—pancreatic cancer	0.000157	0.00104	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000155	0.00103	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000152	0.00101	CcSEcCtD
Pioglitazone—Urticaria—Fluorouracil—pancreatic cancer	0.000152	0.00101	CcSEcCtD
Pioglitazone—Headache—Sunitinib—pancreatic cancer	0.000152	0.00101	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—pancreatic cancer	0.000152	0.00101	CcSEcCtD
Pioglitazone—Weight increased—Epirubicin—pancreatic cancer	0.000149	0.000992	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—pancreatic cancer	0.000148	0.000986	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000148	0.000983	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—pancreatic cancer	0.000148	0.000982	CcSEcCtD
Pioglitazone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000147	0.000979	CcSEcCtD
Pioglitazone—Hypertension—Docetaxel—pancreatic cancer	0.000146	0.000972	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—pancreatic cancer	0.000146	0.000971	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—pancreatic cancer	0.000146	0.000971	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—pancreatic cancer	0.000146	0.00097	CcSEcCtD
Pioglitazone—Arthralgia—Docetaxel—pancreatic cancer	0.000144	0.000958	CcSEcCtD
Pioglitazone—Myalgia—Docetaxel—pancreatic cancer	0.000144	0.000958	CcSEcCtD
Pioglitazone—Chest pain—Docetaxel—pancreatic cancer	0.000144	0.000958	CcSEcCtD
Pioglitazone—Asthenia—Irinotecan—pancreatic cancer	0.000143	0.000953	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000143	0.000952	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—pancreatic cancer	0.000142	0.000944	CcSEcCtD
Pioglitazone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000141	0.000938	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000141	0.000937	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—pancreatic cancer	0.00014	0.000931	CcSEcCtD
Pioglitazone—Asthenia—Gemcitabine—pancreatic cancer	0.00014	0.000929	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—pancreatic cancer	0.000139	0.000926	CcSEcCtD
Pioglitazone—Oedema—Docetaxel—pancreatic cancer	0.000138	0.000919	CcSEcCtD
Pioglitazone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000138	0.000919	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—pancreatic cancer	0.000138	0.000917	CcSEcCtD
Pioglitazone—Infection—Docetaxel—pancreatic cancer	0.000137	0.000913	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—pancreatic cancer	0.000137	0.000912	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—pancreatic cancer	0.000137	0.000911	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000137	0.000909	CcSEcCtD
Pioglitazone—Diarrhoea—Irinotecan—pancreatic cancer	0.000137	0.000909	CcSEcCtD
Pioglitazone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000136	0.000901	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—pancreatic cancer	0.000135	0.000899	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—pancreatic cancer	0.000135	0.000899	CcSEcCtD
Pioglitazone—Skin disorder—Docetaxel—pancreatic cancer	0.000134	0.000892	CcSEcCtD
Pioglitazone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000133	0.000886	CcSEcCtD
Pioglitazone—Dizziness—Irinotecan—pancreatic cancer	0.000132	0.000879	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000131	0.000874	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—pancreatic cancer	0.000131	0.000872	CcSEcCtD
Pioglitazone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000131	0.000871	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000131	0.000868	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—pancreatic cancer	0.00013	0.000866	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—pancreatic cancer	0.00013	0.000862	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00013	0.000861	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—pancreatic cancer	0.000129	0.000859	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—pancreatic cancer	0.000129	0.000857	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000129	0.000857	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—pancreatic cancer	0.000129	0.000855	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—pancreatic cancer	0.000127	0.000843	CcSEcCtD
Pioglitazone—Dizziness—Fluorouracil—pancreatic cancer	0.000127	0.000842	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—pancreatic cancer	0.000126	0.00084	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000126	0.000837	CcSEcCtD
Pioglitazone—Headache—Irinotecan—pancreatic cancer	0.000125	0.000832	CcSEcCtD
Pioglitazone—Insomnia—Docetaxel—pancreatic cancer	0.000125	0.000831	CcSEcCtD
Pioglitazone—Dyspnoea—Docetaxel—pancreatic cancer	0.000123	0.000819	CcSEcCtD
Pioglitazone—Eye disorder—Epirubicin—pancreatic cancer	0.000123	0.000815	CcSEcCtD
Pioglitazone—Headache—Gemcitabine—pancreatic cancer	0.000122	0.000811	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—pancreatic cancer	0.000122	0.000809	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—pancreatic cancer	0.000121	0.000807	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000121	0.000803	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—pancreatic cancer	0.00012	0.000801	CcSEcCtD
Pioglitazone—Headache—Fluorouracil—pancreatic cancer	0.00012	0.000797	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00012	0.000797	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00012	0.000795	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000119	0.000793	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000119	0.000793	CcSEcCtD
Pioglitazone—Fatigue—Docetaxel—pancreatic cancer	0.000119	0.000792	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—pancreatic cancer	0.000119	0.000791	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—pancreatic cancer	0.000119	0.000788	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000118	0.000786	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—pancreatic cancer	0.000117	0.000778	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—pancreatic cancer	0.000114	0.000759	CcSEcCtD
Pioglitazone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000114	0.000757	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—pancreatic cancer	0.000113	0.000754	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000113	0.000749	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—pancreatic cancer	0.000113	0.000748	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—pancreatic cancer	0.00011	0.000734	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—pancreatic cancer	0.00011	0.00073	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—pancreatic cancer	0.00011	0.000729	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000109	0.000727	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000106	0.000704	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—pancreatic cancer	0.000106	0.000702	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—pancreatic cancer	0.000106	0.000702	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—pancreatic cancer	0.000104	0.000692	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—pancreatic cancer	0.000103	0.000685	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—pancreatic cancer	0.000103	0.000682	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—pancreatic cancer	0.000102	0.000679	CcSEcCtD
Pioglitazone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000102	0.000677	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—pancreatic cancer	0.000102	0.000675	CcSEcCtD
Pioglitazone—Asthenia—Docetaxel—pancreatic cancer	9.92e-05	0.000659	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—pancreatic cancer	9.86e-05	0.000655	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.81e-05	0.000652	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—pancreatic cancer	9.77e-05	0.000649	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—pancreatic cancer	9.72e-05	0.000646	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—pancreatic cancer	9.72e-05	0.000646	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—pancreatic cancer	9.72e-05	0.000646	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	9.66e-05	0.000642	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—pancreatic cancer	9.61e-05	0.000639	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—pancreatic cancer	9.53e-05	0.000633	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—pancreatic cancer	9.49e-05	0.000631	CcSEcCtD
Pioglitazone—Diarrhoea—Docetaxel—pancreatic cancer	9.46e-05	0.000628	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—pancreatic cancer	9.32e-05	0.00062	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—pancreatic cancer	9.32e-05	0.00062	CcSEcCtD
Pioglitazone—Infection—Epirubicin—pancreatic cancer	9.26e-05	0.000616	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—pancreatic cancer	9.14e-05	0.000608	CcSEcCtD
Pioglitazone—Dizziness—Docetaxel—pancreatic cancer	9.14e-05	0.000607	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—pancreatic cancer	9.12e-05	0.000606	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—pancreatic cancer	9.05e-05	0.000602	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—pancreatic cancer	9.01e-05	0.000599	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—pancreatic cancer	9e-05	0.000598	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—pancreatic cancer	9e-05	0.000598	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—pancreatic cancer	9e-05	0.000598	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.94e-05	0.000594	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—pancreatic cancer	8.89e-05	0.000591	CcSEcCtD
Pioglitazone—Headache—Docetaxel—pancreatic cancer	8.66e-05	0.000575	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—pancreatic cancer	8.63e-05	0.000573	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.63e-05	0.000573	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—pancreatic cancer	8.57e-05	0.00057	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.49e-05	0.000564	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—pancreatic cancer	8.46e-05	0.000562	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—pancreatic cancer	8.43e-05	0.00056	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—pancreatic cancer	8.38e-05	0.000557	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.34e-05	0.000554	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—pancreatic cancer	8.31e-05	0.000552	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.05e-05	0.000535	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—pancreatic cancer	8.04e-05	0.000534	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.86e-05	0.000522	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—pancreatic cancer	7.8e-05	0.000519	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—pancreatic cancer	7.69e-05	0.000511	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—pancreatic cancer	7.68e-05	0.000511	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.45e-05	0.000495	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—pancreatic cancer	7.44e-05	0.000494	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—pancreatic cancer	7.41e-05	0.000492	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—pancreatic cancer	7.11e-05	0.000472	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—pancreatic cancer	6.87e-05	0.000456	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—pancreatic cancer	6.85e-05	0.000455	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—pancreatic cancer	6.69e-05	0.000445	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—pancreatic cancer	6.38e-05	0.000424	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—pancreatic cancer	6.35e-05	0.000422	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—pancreatic cancer	6.19e-05	0.000411	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—pancreatic cancer	6.16e-05	0.00041	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—pancreatic cancer	5.9e-05	0.000392	CcSEcCtD
Pioglitazone—Headache—Epirubicin—pancreatic cancer	5.84e-05	0.000388	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—pancreatic cancer	5.7e-05	0.000379	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—pancreatic cancer	5.4e-05	0.000359	CcSEcCtD
